These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8016178)

  • 1. Structure-activity relationship studies of CNS agents. Part 10(1): 1-Aryl-2-[3-(4-aryl-1-piperazinyl)propyl]-1,4-dihydro-3(2H)-isoquino linones: two modes of the interaction with the 5-HT1A receptor site.
    Mokrosz JL; Bojarski AJ; Maćkowiak M; Bielecka Z; Boksa J
    Pharmazie; 1994 May; 49(5):328-33. PubMed ID: 8016178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship studies of CNS agents. Part VII. The effect of the imidazole fragment in 2-substituted 1-[3-(4-aryl-1-piperazinyl)propyl]imidazoles on their interaction modes with 5-HT1A and 5-HT2 receptors.
    Mokrosz JL; Duszyńska B
    Pol J Pharmacol Pharm; 1992; 44(5):527-38. PubMed ID: 1297115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
    Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
    J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
    J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of a new model of arylpiperazines. 3.1 2-[omega-(4-arylpiperazin-1-yl)alkyl]perhydropyrrolo- [1,2-c]imidazoles and -perhydroimidazo[1,5-a]pyridines: study of the influence of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Murcia M; Sanz AM; Orensanz L
    J Med Chem; 1997 Aug; 40(16):2653-6. PubMed ID: 9258372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives as high-affinity, selective 5-HT1A receptor ligands.
    Modica M; Santagati M; Russo F; Parotti L; De Gioia L; Selvaggini C; Salmona M; Mennini T
    J Med Chem; 1997 Feb; 40(4):574-85. PubMed ID: 9046348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the aliphatic spacer length on the 5-HT1A receptor activity of new arylpiperazines with an indazole system.
    Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E
    Pol J Pharmacol; 2000; 52(3):209-16. PubMed ID: 11055578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
    Boksa J; Klodzińska A; Charakchieva-Minol S; Chojnacka-Wójcik E; Mokrosz JL
    Pharmazie; 1996 Feb; 51(2):72-6. PubMed ID: 8720802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT1A and 5-HT2A receptor affinity and functional profile of some N-[3-(4-aryl-1-piperazinyl)propyl] derivatives of indolin-2(1H)-one, quinolin-2(1 H)-one and isoquinolin-1(2H)-one. Part 30: Structure-activity relationship studies of CNS agents.
    Mokrosz MJ; Mokrosz JL; Duszyńska B; Dereń-Wesołek A; Kłodzińska A; Kowalski P; Charakchieva-Minol S; Tatarczyńska E; Kowalska T; Majka Z; Chojnacka-Wójcik E; Misztal S
    Pharmazie; 1997 Jun; 52(6):423-8. PubMed ID: 9260266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship studies of CNS agents. Part VIII. Bulk tolerance around the protonation center of 4-substituted 1-(3-chlorophenyl)piperazines at 5-HT1A and 5-HT2 receptors.
    Mokrosz JL; Charakchieva-Minol S; Paluchowska MH; Cegła MT
    Pol J Pharmacol Pharm; 1992; 44(6):595-607. PubMed ID: 1305959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
    Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH
    Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-beta-carbolines.
    Bojarski AJ; Cegła MT; Charakchieva-Minol S; Mokrosz MJ; Maćkowiak M; Misztal S; Mokrosz JL
    Pharmazie; 1993 Apr; 48(4):289-94. PubMed ID: 8321880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 3-aryl-1-[(4-phenyl-1-piperazinyl)butyl]indazole derivatives and their affinity to 5-HT1A serotonin and dopamine D1 receptors.
    Andronati S; Sava V; Makan S; Kolodeev G
    Pharmazie; 1999 Feb; 54(2):99-101. PubMed ID: 10084155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
    Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
    J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
    López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Sanz AM; Orensanz L; Beneitez ME; Fuentes JA; Manzanares J
    J Med Chem; 1996 Oct; 39(22):4439-50. PubMed ID: 8893838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of linking bridge modifications on the 5-HT1A receptor activity of some 4-(omega-benzotriazol-1-yl)alkyl-1-(2-methoxy-phenyl)piperazines.
    Paluchowska MH; Kłodzińska A; Tatarczyńska E; Szaro A; Chojnacka-Wójcik E
    Pol J Pharmacol; 1998; 50(4-5):341-7. PubMed ID: 10091719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 10-substituted 11-oxygenated (R)-aporphines: synthesis, pharmacology, and modeling of 5-HT1A receptor interactions.
    Hedberg MH; Jansen JM; Nordvall G; Hjorth S; Unelius L; Johansson AM
    J Med Chem; 1996 Aug; 39(18):3491-502. PubMed ID: 8784447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
    Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
    Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3.
    Perrone R; Berardi F; Leopoldo M; Tortorella V; Fornaretto MG; Caccia C; McArthur RA
    J Med Chem; 1996 Aug; 39(16):3195-202. PubMed ID: 8759642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
    J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.